IN VITRO & IN VIVO EVALUATION OF PRAMIPEXOLE HCL MUCOADHESIVE MICROSPHERES

Authors

  • K. Subbarao Mewar University, NH-79, Gangrar, Chhitorgarh-312901, Rajasthan, India
  • G. Suresh Mewar University, NH-79, Gangrar, Chhitorgarh-312901, Rajasthan, India

Abstract

The study was aimed to design and develop the novel gastro retentive mucoadhesive Pramipexole microspheres using ionotropic gelation technique. Based on the results of Micromeretic properties confirmed that microspheres were free flowing with good pack ability. The optimized M13 formulation displayed the % entrapment efficiency 96.07%, % yield 98.01%, swelling index 96.08% and Mucoadhesiveness was 95.42%. The in vitro drug release showed the sustained release of Pramipexole up to 99.16 ± 5.12% within 12 h. FTIR studies revealed incompatibility was not found between drug and excipients. SEM confirmed the particles were of spherical in shape. Optimized formulation (M13) were stable at 40°C ± 2°C/75% RH ± 5% RH for 6 months. In vivo studies were performed and kinetic parameters like Cmax, Tmax, AUC0-t, AUC0-∞ and t1/2 were calculated. The marketed product Cmax (2.19 ± 0.01 ng/ml) was higher than optimized formulation (2.0 ± 0.01 ng/ml). The optimized formulation AUC0-t (20.15 ± 1.12 ng.hr/ml), AUC0-∞ (27.42 ± 1.16 ng.hr/ml) was significantly higher than that of marketed product AUC0-t (13.21 ± 1.26 ng.hr/ml) and AUC0-∞ (19.15 ± 1.13 ng.hr/ml) respectively. Which indicated the optimized formulation bioavailability was higher than marketed product. Microspheres would be a promising drug delivery system which plays potentially significant role in pharmaceutical drug delivery in the efficient management of Parkinson’s disease.

Keywords:

Pramipexole, Mucoadhesive microspheres, In vivo bioavailability studies, Parkinson’s disease

DOI

https://doi.org/10.25004/IJPSDR.2018.100509

References

1. Prakash G, Sathish A, Mobben M, Sarika M, Banu T, Ramakrishna R. Formulation and evaluation of mucoadhesive microspheres of pioglitazone hydrochloride using a natural polymer. International Journal of Pharma Sciences and Research. 2015; 6: 723-735.
2. Hardenia SS, Jain A, Patel R, Kaushal A. Formulation and Evaluation of Mucoadhesive Microspheres of Ciprofloxacin. Journal of Advanced Pharmacy Education & Research. 2011; 1(4): 214-224.
3. Sriram N, Katakam P. Formulation and Evaluation of Mucoadhesive Microspheres of Pioglitazone Hydrochloride Prepared by Ionotropic External Gelation Technique. J Encap Ads Sci. 2016; 6 (1): 22-34.
4. Li Y, He H. Preparation stability and pharmacokinetics evaluation of lipid microspheres loading a promising antitumor candidate Timataxel. Asian J pharm Sci. 2016; 11 (6): 771–79.
5. Brooks DJ. Dopamine agonists their role in the treatment of Parkinson's disease Journal of Neurology, Neurosurgery & Psychiatry. 2000; 68: 685-689.
6. Bhatt N, Bhatt G, Kothiyal P. Drug delivery to the brain using polymeric nanoparticles: a review. International Journal of Pharmaceutical and Life Sciences. 2013; 2(3):107-132.
7. Fazil M, Md S, Haque S, Kumar M, Baboota S, Sahni JK, Ali J. Development and evaluation of rivastigmine loaded chitosan nanoparticles for brain targeting. Eur J Pharm Sci. 2012; 47(1):6-15.
8. Chang J, Jallouli Y, Kroubi M, Yuan XB, Feng W, Kang CS, Pu PY, Betbeder D. Characterization of endocytosis of transferrin-coated PLGA nanoparticles by the blood-brain barrier. International Journal of Pharmaceutics. 2009; 379(2): 285–292.
9. Krishna Sailaja A, Amareshwar P, Chakravarty P. Different techniques used for the preparation of nanoparticles using natural polymers and their application. International Journal of Pharmacy and Pharmaceutical Science. 2011; 3(2): 45-50.
10. Trapani A, De Giglio E, Cafagna D, Denora N, Agrimi G, Cassano T, Gaetani S, Cuomo V, Trapani G. Characterization and evaluation of chitosan nanoparticles for dopamine brain delivery. International Journal of Pharmaceutics. 2011; 419(1-2): 296– 307.
11. Huang R, Ma H, Guo Y, Liu S, Kuang Y, Shao K, Li J, Liu Y, Han L, Huang S, An S, Ye L, Lou J, Jiang C. Conjugated nanoparticles for targeted long-term gene therapy of Parkinson’s disease. Pharm Res. 2013; 30(10): 2549-59.
12. Lumb V, Das MK, Singh N, Dev V, Khan W, Sharma YD. Multiple Origins of Plasmodium falciparum Dihydropteroate Synthetase Mutant Alleles Associated with Sulfadoxine Resistance in India. Antimicrob Agents Chemother. 2011; 55(6): 2813–2817.
13. Cosco D, Failla P, Costa N, Pullano S, Fiorillo A, Mollace V, Fresta M, Paolino D. Rutin-loaded Chitosan Microspheres: Characterization and Evaluation of the Anti-Inflammatory Activity. Carbohydrate polymers. 2016; 152: 583-591.
14. Kaur R, Gulati M, Singh SK. Role of synbiotics in polysaccharide assisted colon targeted microspheres of Mesalamine for the treatment of ulcerative colitis. International Journal of Biological Macromolecules. 2017; 95: 438-450.
15. Wang QS, Wang GF, Zhou J, Gao LN, Cui YL. Colon targeted oral drug delivery system based on chitosan/alginate microspheres loaded with icariin in the treatment of ulcerative colitis. International Journal of Pharmaceutics. 2016; 515(1-2): 176-185.
16. Piacentini E, Yan M, Giorno L. Development of enzyme-loaded PVA microspheres by Membrane Emulsification. Journal of Membrane Science. 2016; 524: 79-86.
17. Małgorzata W, Marcin Z, Aleksandra A. Tasting cetirizine-based microspheres with an electronic tongue. Sensors and Actuators B Chemical. 2016; 238: 1190-1198.
18. Maarten J, Ufuk TT, Nina W. Celecoxib-loaded PEA microspheres as an auto regulatory drug-delivery system after intra-articular injection. Journal of Controlled Release. 2016; 244: 30-40.
19. Velmurugan S, Ali MA. Formulation and evaluation of maraviroc mucoadhesive microsheres by ionotropic gelation method. International journal of pharmacy and pharmaceutical sciences. 2013; 5(4): 294-302.
20. Tyagi LK, Kori ML. Stability Study and In-vivo Evaluation of Lornoxicam Loaded Ethyl Cellulose Microspheres. International Journal of Pharmaceutical Sciences and Drug Research. 2014; 6(1): 26-30.
21. Begum A, Basava Raju D. Formulation and Evaluation of Controlled Release Roxatidine Acetate HCl Mucoadhesive Microspheres: In-vivo Study. Research Journal of Pharmaceutical, Biological and Chemical Sciences. 2016; 7(4): 1525-1532.
22. Sevim S, Erk N. Validation of high performance liquid chromatographic and spectrophotometric methods for the determination of the antiparkinson agent pramipexole dihydrochloride monohydrate in pharmaceutical products. Brazilian Journal of Pharmaceutical Sciences. 2015; 51(4): 880-891.

Published

01-09-2018
Statistics
Abstract Display: 401
PDF Downloads: 575
Dimension Badge

How to Cite

“IN VITRO & IN VIVO EVALUATION OF PRAMIPEXOLE HCL MUCOADHESIVE MICROSPHERES”. International Journal of Pharmaceutical Sciences and Drug Research, vol. 10, no. 5, Sept. 2018, pp. 418-25, https://doi.org/10.25004/IJPSDR.2018.100509.

Issue

Section

Research Article

How to Cite

“IN VITRO & IN VIVO EVALUATION OF PRAMIPEXOLE HCL MUCOADHESIVE MICROSPHERES”. International Journal of Pharmaceutical Sciences and Drug Research, vol. 10, no. 5, Sept. 2018, pp. 418-25, https://doi.org/10.25004/IJPSDR.2018.100509.